Search Results - "Carballas, E."

Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients by Rodriguez-Freixinos, V., Fariñas-Madrid, L., Gil-Martin, M., Barretina-Ginesta, P., Romeo, M., Villacampa, G., Pardo, B., Ahmed, H., Recalde, S., Piulats, J.M., Gómez-Plaza, M.C., Gil-Moreno, A., Sala, E., Martínez-Román, S., Ponce, J., Meléndez, C., Carballas, E., Dienstmann, R., Oaknin, A.

“…The hallmarks of germline(g) and/or somatic(s) BRCA1/2 mutation ovarian cancer (BMOC) patients are increased sensitivity to platinum-based chemotherapy (PCT)…”
Get full text

Corrigendum to ‘Chemotherapy and PARP inhibitors in heavily pretreated BRCA1/2 mutation ovarian cancer (BMOC) patients’ [Gynecologic Oncology 152 (2019) 270-277] by Rodriguez-Freixinos, V., Fariñas-Madrid, L., Gil-Martin, M., Barretina-Ginesta, P., Romeo, M., Villacampa, G., Pardo, B., Ahmed, H., Recalde, S., Piulats, J.M., Gomez-Plaza, M.C., Gil-Moreno, A., Sala, E., Martínez-Roman, S., Ponce, J., Melendez, C., Carballas, E., Dienstmann, R., Oaknin, A.

Get full text

How can we help our gynaecological cancer patients during the COVID-19 pandemic? by Martínez-Román, S, Tarrats, A, Carballas, E, Romeo, M

Get full text

Cómo podemos ayudar a nuestras pacientes con cáncer ginecológico durante la pandemia de la COVID-19? by Martínez-Román, S., Tarrats, A., Carballas, E., Romeo, M.

Get full text

The prognostic impact of monocyte to lymphocyte ratio (MLR) in advanced epithelial ovarian cancer (EOC) by Salamero, M Cucurull, Te García, I ruel, Arroyo, A.J., Pardo, B., Gil, M., Piulats, J.M., Pla, H., Fina, C., Ginesta, M P Barretina, Angelats, L., Falgas, E Felip, Lecuona, C Erasun, Mosquera, J J García, Román, S Martinez, Carballas, E., Hernandez, J., Esteve, A., Romeo, M.

Get full text

1021PThe prognostic impact of monocyte to lymphocyte ratio (MLR) in advanced epithelial ovarian cancer (EOC) by Salamero, M Cucurull, García, I Teruel, Arroyo, A J, Pardo, B, Gil, M, Piulats, J M, Pla, H, Fina, C, Ginesta, M P Barretina, Angelats, L, Falgas, E Felip, Lecuona, C Erasun, Mosquera, J J García, Román, S Martinez, Carballas, E, Hernandez, J, Esteve, A, Romeo, M

“…Abstract Background Among the inflammation-related biomarkers, high MLR values are associated to poorer outcomes in different cancers. We explored the…”
Get full text

1021P - The prognostic impact of monocyte to lymphocyte ratio (MLR) in advanced epithelial ovarian cancer (EOC) by Salamero, M Cucurull, Te García, I ruel, Arroyo, A.J., Pardo, B., Gil, M., Piulats, J.M., Pla, H., Fina, C., Ginesta, M P Barretina, Angelats, L., Falgas, E Felip, Lecuona, C Erasun, Mosquera, J J García, Román, S Martinez, Carballas, E., Hernandez, J., Esteve, A., Romeo, M.

“…Among the inflammation-related biomarkers, high MLR values are associated to poorer outcomes in different cancers. We explored the prognostic role of MLR in a…”
Get full text

Impact of chemotherapy (CT) in heavily pretreated BRCA1/2 mutation carrier ovarian cancer (BMCOC) patients (pts) by Rodriguez Freixinos, V., Fariñas Madrid, L., Gil Martin, M., Barretina, P., Romeo Marin, M., Villacampa Javierre, G., VIAPLANA, C., Pardo, B., Ahmed Ouahid, H., Recalde, S., Piulats Rodriguez, J.M., Gomez, M.C., Gil-Moreno, A., Sala, E., Martinez-Román, S., Melendez, C., Carballas, E., Dienstmann, R., Oaknin, A.

Get full text

Cómo podemos ayudar a nuestras pacientes con cáncer ginecológico durante la pandemia de la COVID-19? by Martínez-Román, S., Tarrats, A., Carballas, E., Romeo, M.

Get full text

Cirugía radical en mujer joven con tumor de ovario borderline de alto grado: a propósito de un caso by Sagrera Rectoret, D., Tarrats Oliva, A., Martínez Román, S., Framis Utset, M., Carballas Valencia, E.

“…Los tumores de ovario borderline se caracterizan por exhibir un comportamiento intermedio entre los tumores benignos y los carcinomas invasivos. Generalmente…”
Get full text